1 documents found
Information × Registration Number 0120U104457, R & D request Title A multicenter, double-blind, randomized, placebo-controlled phase 3 study to evaluate the efficacy, safety and tolerability of itraconazole as a dry inhalation powder for the prevention of fungal mycosis in patients with acute leukemia and neurotropenia Head Skrypnyk Ihor M., д.мед.н. Registration Date 21-10-2020 Organization Ukrainian medical stomatological Academy popup.description1 Phase 3 study to evaluate the efficacy, safety and tolerability of itraconazole in the form of dry powder for inhalation for the prevention of mold mycosis in patients with acute leukemia and neurotropenia popup.nrat_date 2024-12-10 Close
search.res_rk
Head: Skrypnyk Ihor M.. A multicenter, double-blind, randomized, placebo-controlled phase 3 study to evaluate the efficacy, safety and tolerability of itraconazole as a dry inhalation powder for the prevention of fungal mycosis in patients with acute leukemia and neurotropenia. Ukrainian medical stomatological Academy. № 0120U104457
1 documents found

Updated: 2026-03-18